866-997-4948(US-Canada Toll Free)

Uterine Fibroids Treatment Market - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016 - 2024

Published By :

Transparency Market Research

Published Date : Nov 2016

Category :

Pharmaceutical

No. of Pages : 102 Pages

U.S. Uterine Fibroids Market: Snapshot

The uterine fibroid treatment market is driven by growing number of hysterectomy surgeries every year in the country. Furthermore, the rising coverage of healthcare and increasing prevalence of non-cancerous tumors in women of childbearing age is expected to be the most vital reason for expansion of the uterine fibroids market growth. Now a days, fibroids are an important public health concern, due of the large number of women affected by the problem and the large number of hysterectomy procedure are done to treat the symptoms. 

The National Institute of Health (NIH) conducts research on uterine fibroids, supports studies of fibroids at academic institutions, and sponsors interdisciplinary conferences where researchers share and discuss the results of their studies. Medical therapy is used for many women who have symptoms from fibroids and sometimes is used prior to surgery to shrink the fibroids. Commercially available drugs that shrink fibroids include gonadotropin-releasing hormones, which usually cause symptoms of menopause. Drugs that block the hormone progesterone can slow or stop the growth of fibroids. Some health care providers may use hormonal or over-the-counter medications to control pain and bleeding. 

U.S. Uterine Fibroids Market: Trends and Opportunities

According to the U.S. Department of Health and Human Services Office on Women’s Health, about 30 percent of all women will get them by age 35, and around 20-80 percent of women will do so by age 50. For some reason, African American women are more likely to experience fibroids, and to do so at a younger age. As women age, fibroid growth rates decline for most women, but not for African American women. Several treatment options are available now a days, which are driving the overall uterine fibroids market such as self-help techniques, drug therapy, uterine artery embolization and less invasive surgical procedures (myomectomy & hysterectomy). 

The report is a combination of primary and secondary research. Primary research formed the bulk of our research efforts, with information collected from telephonic interviews and interactions via e-mail. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various national and international databases. The report provides market size in terms of US$ Mn for each segment for the period from 2016 to 2024, considering the macro and micro-environmental factors. Growth rates for each segment within the U.S uterine fibroids market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, vaccination expenditure, and regulatory requirements. 

U.S. Uterine Fibroids Market: Drivers and Restraints

The market overview section of the report includes qualitative analysis of the overall uterine fibroids market including the determining factors and market dynamics such as drivers, restraints, market trends and opportunities, along with white space analysis. In addition, market attractiveness analysis by country and end-user along with competitive landscape by key players have been provided which explain the intensity of competition in the market. The competitive scenario between market players has been evaluated through market share analysis. These factors would help the market players take strategic decisions in order to strengthen their positions and increase their shares in the global market. Pricing analysis holds a crucial part of the report, which further describes the cost to end-user and cost to patient.

The market is driven by changing prevalence of cancerous tumors. The market is projected to grow due to increasing investment in healthcare sector. In terms of distribution channel segment orthopedic clinics is projected to expand at a high CAGR on the backdrop of growing investment healthcare during sports injuries. The hospitals and ambulatory surgical center segment are expected to expand at a significant CAGR over the forecast period. 

Geographically, the U.S uterine fibroids market is showing a substantial growth due to increasing direct and indirect investments by the government and other private companies. Increasing investments and penetration by key market players globally are expected to drive the uterine fibroids market during the forecast period. 

Key Players Mentioned in the Report are:

Key companies profiled in the report include Blue Endo, Richard Wolf Medical Instruments, Boston Scientific Corporation, Cooper Surgical, Halt Medical, Inc., Karl Storz, LiNA Medical USA, Merit Medical Systems, Olympus Corporation, Richard Wolf GmbH and Halt Medical, Inc. 

The orthopedic braces & supports, casting and splints market has been segmented as follows:

Procedure Type

  • Endometrial Ablation
  • MRI Guided Procedures
  • Hysterectomy
  • Myomectomy
  • Uterine Artery Embolization
  • Radiofrequency Ablation
  • Others

Procedure Sub Type

  • MRI Guided Procedures
  • MRI-guided Percutaneous Laser Ablation
  • MRI Guided Transcutaneous Focused Ultrasound
  • Hysterectomy
  • Abdominal Hysterectomy
  • Vaginal Hysterectomy
  • Laparoscopic Hysterectomy
  • Robotic Hysterectomy
  • Hysteroscopic Morcellation
  • Myomectomy
  • Open Myomectomy
  • Laparoscopic Myomectomy
  • Robotic Myomectomy

U.S. Uterine Fibroid Treatment Market, by End User

  • Hospitals
  • Ambulatory Surgical Centers

U.S. Uterine Fibroid Treatment Market, by Geography

  • U.S.

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : U.S. Uterine Fibroid Treatment Market

4. Market Overview
4.1. Introduction
4.1.1. Industry Evolution / Developments
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.5. U.S. Uterine Fibroid Treatment Market Analysis and Forecasts, 2014–2024
4.5.1. Market Revenue Projections, 2014–2024
4.6. Disease Epidemiology and Treatment
4.7. Porter’s Five Force Analysis
4.8. Market Outlook

5. U.S. Uterine Fibroid Treatment Market Analysis and Forecasts, by Procedure Type, 2016–2024
5.1. Introduction & Definition
5.2. Key Findings/Developments
5.3. Market Value (US$ Mn) Forecast, by Procedure Type, 2016–2024
5.3.1. Endometrial Ablation
5.3.2. MRI Guided Procedures
5.3.3. Hysterectomy
5.3.4. Myomectomy
5.3.5. Uterine Artery Embolization 
5.3.6. Radiofrequency Ablation
5.3.7. Others
5.4. Procedure Type Comparison Matrix
5.5. Market Attractiveness, by Procedure Type, 2016–2024

6. U.S. Uterine Fibroid Treatment Market Analysis and Forecasts, by Procedure Type Sub-segment, 2016–2024
6.1. Market Value (US$ Mn) Forecast, by Procedure Type Sub-segment, 2016–2024
6.1.1. MRI Guided Procedures
6.1.1.1. MRI-guided Percutaneous Laser Ablation
6.1.1.2. MRI Guided Transcutaneous Focused Ultrasound
6.1.2. Hysterectomy
6.1.2.1. Abdominal Hysterectomy
6.1.2.2. Vaginal Hysterectomy
6.1.2.3. Laparoscopic Hysterectomy
6.1.2.4. Robotic Hysterectomy
6.1.2.5. Hysteroscopic Morcellation
6.1.3. Myomectomy
6.1.3.1. Open Myomectomy
6.1.3.2. Laparoscopic Myomectomy
6.1.3.3. Robotic Myomectomy
6.2. Market Attractiveness, by Procedure Type Sub-segment, 2016–2024

7. U.S. Uterine Fibroid Treatment Market Analysis and Forecasts, by End-user, 2016–2024
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value (US$ Mn) Forecast, by End-user, 2016–2024
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.4. End-user Comparaison Matrix
7.5. Market Attractiveness, by End-user 

8. U.S. Uterine Fibroid Treatment Procedure Volume Analysis and Forecasts – 2010–2015 & 2016–2024
8.1. Endometrial Ablation
8.2. MRI Guided Procedures
8.2.1. MRI-guided Percutaneous Laser Ablation
8.2.2. MRI Guided transcutaneous focused Ultrasound
8.3. Hysterectomy
8.3.1. Abdominal Hysterectomy
8.3.2. Vaginal Hysterectomy
8.3.3. Laparoscopic Hysterectomy
8.3.4. Robotic Hysterectomy
8.3.5. Hysteroscopic Morcellation
8.4. Myomectomy
8.4.1. Open Myomectomy
8.4.2. Laparoscopic Myomectomy
8.4.3. Robotic Myomectomy
8.5. Uterine Artery Embolisation
8.6. Radiofrequency Ablation
8.7. Others

9. Competition Landscape
9.1. Market Player – Competition Matrix (By Tier and Size of companies)
9.2. Market Share Analysis, by Company (2015)
9.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
9.3.1. Blue Endo
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Business Strategies
9.3.2. Boston Scientific Corporation
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Business Strategies
9.3.3. CooperSurgical, Inc.
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Business Strategies
9.3.4. Karl Storz
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Business Strategies
9.3.5. Halt Medical, Inc.
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Business Strategies
9.3.6. LiNA Medical USA
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Business Strategies
9.3.7. Merit Medical Systems
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Business Strategies
9.3.8. Olympus Corporation
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Business Strategies
9.3.9. Richard Wolf GmbH
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Business Strategies

List of Table

Table 01: U.S. Uterine Fibroid Treatment Market Size (US$ Mn) Forecast, by Procedure Type, 2014–2024
Table 02: U.S. Uterine Fibroid Treatment Market Size (US$ Mn) Forecast, by MRI Guided Procedure Type, 2014–2024
Table 03: U.S. Uterine Fibroid Treatment Market Size (US$ Mn) Forecast, by Hysterectomy Procedure Type, 2014–2024
Table 04: U.S. Uterine Fibroid Treatment Market Size (US$ Mn) Forecast, by Myomectomy Procedure Type, 2014–2024
Table 05: U.S. Uterine Fibroid Treatment Market Value (US$ Mn) Forecast, by End-user, 2014–2024
Table 06: U.S. Uterine Fibroid Treatment Market Forecast, by Procedure Type, 2010–2024

List of Chart

Figure 01: US Uterine Fibroid Treatment Market Revenue (US$ Mn) Forecast, 2014–2024
Figure 02: U.S. Endometrial Ablation Market Revenue (US$ Mn), 2014–2024
Figure 03: U.S. MRI Guided Procedures Market Revenue (US$ Mn), 2014–2024
Figure 04: U.S. Hysterectomy Market, Revenue (US$ Mn), 2014–2024
Figure 05: U.S. Myomectomy Market, Revenue (US$ Mn), 2014–2024
Figure 06: U.S. Endometrial Ablation Devices Market, Revenue (US$Mn), 2014–2024
Figure 07: U.S. Radiofrequency Ablation Devices Market, Revenue (US$ Mn), 2014–2024
Figure 08: U.S. Other Procedure Market, Revenue (US$Mn), 2014–2024
Figure 09: U.S. Uterine Fibroid Market Attractiveness Analysis, by Procedure Type, 2016 – 2024
Figure 10: U.S. MRI-guided Percutaneous Laser Ablation Market Revenue (US$ Mn), 2014–2024
Figure 11: U.S. MRI guided Transcutaneous Focused Ultrasound Market Revenue (US$ Mn), 2014–2024
Figure 12: U.S. Abdominal Hysterectomy Market, Revenue (US$ Mn), 2014–2024
Figure 13: U.S. Vaginal Hysterectomy Market, Revenue (US$ Mn), 2014–2024
Figure 14: U.S. Laparoscopic Hysterectomy Market, Revenue (US$ Mn), 2014–2024
Figure 15: U.S. Robotic Hysterectomy Market, Revenue (US$ Mn), 2014–2024
Figure 16: U.S. Hysteroscopic Morcellation Market, Revenue (US$ Mn), 2014–2024
Figure 17: U.S. Open Myomectomy Market, Revenue (US$ Mn), 2014–2024
Figure 18: U.S. Laparoscopic Myomectomy Market, Revenue (US$ Mn), 2014–2024
Figure 19: U.S. Robotic Myomectomy Market, Revenue (US$ Mn), 2014–2024
Figure 20: U.S. Uterine Fibroid Market Attractiveness Analysis, by Procedure Type Sub-segment, 2016 – 2024
Figure 21: U.S. Hospitals Market, Revenue (US$ Mn), 2014–2024
Figure 22: U.S. Ambulatory Surgical Centers Market, Revenue (US$ Mn), 2014–2024
Figure 23: U.S. Uterine Fibroid Market Attractiveness Analysis, by End-user, 2016 – 2024
Figure 24: U.S. Uterine Fibroid Treatment Market Share Analysis, by Company (2015)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *